Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2025
Download Free Sample Buy Now
Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2025

By Type (RNA Interference (RNAi), RNA Antisense), By Technology (Enabling Technology, Enabled Technology), By Therapeutic Area (Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas), By End User (Research Institutes, Hospitals And Clinics ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

• Ribose-Nucleic Acid (RNA)-Based Therapeutics market size has reached to $15.79 billion in 2024

• Expected to grow to $24.11 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%

• Growth Driver: Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market

• Market Trend: Advancements In RNA-Based Therapeutics With mRNA-Based Vaccines

• North America was the largest region in 2024.

What Is Covered Under Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?

The ribose-nucleic acid (RNA)-based therapeutics refer to a class of medical treatments that utilize ribose-nucleic acid (RNA) molecules to influence cellular processes, typically by targeting specific genetic sequences. These therapies are designed to treat various conditions, including genetic disorders, cancers, and infectious diseases, by modulating gene expression, protein production, or cellular signaling pathways.

The main types of ribose-nucleic acid (RNA)-based therapeutics are RNA interference (RNAi) and RNA antisense. RNA interference (RNAi) is a biological process where RNA molecules inhibit gene expression or translation by neutralizing targeted mRNA molecules. The various technologies include enabling technology. It is used for varying therapeutic areas such as oncology, genetic disorders, ophthalmology, hematological disorders, acute hepatic porphyria (AHP), and others by different end users, including research institutes, hospitals, and clinics.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Size 2025 And Growth Rate?

The ribose-nucleic acid (RNA)-based therapeutics market size has grown strongly in recent years. It will grow from $15.79 billion in 2024 to $17.22 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to investment and funding growth, the discovery of RNA interference (RNAi), clinical successes of antisense oligonucleotides (ASOs), regulatory support and frameworks, and collaborations, and partnerships.

What Is The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth Forecast?

The ribose-nucleic acid (RNA)-based therapeutics market size is expected to see strong growth in the next few years. It will grow to $24.11 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the expansion of indications, rising market demand and adoption, regulatory support, integration of AI and machine learning, and emerging applications in rare diseases. Major trends in the forecast period include advanced delivery systems, multi-target RNA therapeutics, customized RNA therapies, regulatory advancements, and commercialization and market growth.

The forecast of 8.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of messenger ribonucleic acid vaccines and lipid nanoparticle delivery systems sourced from Switzerland and Canada, thereby reducing pandemic/disease preparedness and elevating biopharmaceutical research and development expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segmented?

1) By Type: RNA Interference (RNAi), RNA Antisense

2) By Technology: Enabling Technology, Enabled Technology

3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas

4) By End User: Research Institutes, Hospitals And Clinics

Subsegments:

1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)

2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA

What Is Driving The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market? Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market

The increasing prevalence of cancer is expected to propel the growth of the ribose-nucleic acid (RNA)-based therapeutics market going forward. Cancer refers to a condition where abnormal cells grow and spread uncontrollably, potentially leading to death if untreated. The prevalence of cancer is due to an aging population, lifestyle changes, greater exposure to risks, and better detection methods. RNA-based therapeutics offer a promising avenue for cancer treatment by directly targeting the genetic and molecular mechanisms of cancer. For instance, in August 2023, according to the Australian Institute of Health and Welfare, an Australia-based government administration for health, around 151,000 individuals were diagnosed with cancer (excluding basal cell carcinomas (BCC) and squamous cell carcinomas (SCC) of the skin) in 2021, which is expected to reach 185,000 in 2030. Therefore, the increasing prevalence of cancer is driving the ribose-nucleic acid (RNA)-based therapeutics industry.

Who Are The Major Players In The Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?

Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics

What Are The Key Trends Of The Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market? Advancements In RNA-Based Therapeutics With mRNA-Based Vaccines

Major companies operating in the ribose nucleic acid (RNA)-based therapeutics market are focused on developing innovative medication solutions, such as messenger RNA (mRNA)-based booster vaccines, to enhance the effectiveness of immunization, address emerging viral variants, and improve the overall durability of vaccine-induced immunity. An mRNA-based booster vaccine uses messenger RNA to prompt cells to create a protein that enhances the body's immune response against a particular pathogen. For instance, in June 2023, Gennova Biopharmaceuticals Ltd., an India-based pharmaceutical company, launched GEMCOVAC-OM, India's first mRNA booster vaccine specifically targeting the Omicron variant of COVID-19. This booster is essential due to the limited efficacy of the original vaccines against Omicron. Utilizing mRNA technology, GEMCOVAC-OM boosts immunity and offers enhanced protection against the evolving virus.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market? Orna Therapeutics Acquired ReNAgade Therapeutics To Enhance RNA-Based Therapeutics Capabilities

In May 2024, Orna Therapeutics, a US-based biotechnology company focusing on developing RNA-based therapeutics, acquired ReNAgade Therapeutics for an undisclosed amount. Through this acquisition, Orna seeks to enhance its industry-leading strategy by merging its circular RNA expression technology with ReNAgade's extensive LNP-based RNA delivery systems and editing programs. ReNAgade Therapeutics is a US-based biotechnology company specializing in RNA-based therapeutics.

What Is The Regional Outlook For The Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?

North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ribose-Nucleic Acid (RNA)-Based Therapeutics Market?

The ribose-nucleic acid (RNA)-based therapeutics market consists of revenues earned by entities by custom synthesis of RNA, RNA delivery systems, and RNA sequencing analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribose-nucleic acid (RNA)-based therapeutics market also includes the sale of microRNA (miRNA) therapeutics, antisense oligonucleotides, and messenger RNA (mRNA) vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Ribose-Nucleic Acid (RNA)-Based Therapeutics Industry?

The ribose-nucleic acid (rna)-based therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribose-nucleic acid (rna)-based therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $17.22 billion
Revenue Forecast In 2034 $24.11 billion
Growth Rate CAGR of 8.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: RNA Interference (RNAi), RNA Antisense
2) By Technology: Enabling Technology, Enabled Technology
3) By Therapeutic Area: Oncology, Genetic Disorder, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Other Therapeutic Areas
4) By End User: Research Institutes, Hospitals And Clinics Subsegments: 1) By RNA Interference (RNAi): Small Interfering RNA (siRNA), MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs), Antisense RNA
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Characteristics

3. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Trends And Strategies

4. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Growth Rate Analysis

5.4. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Total Addressable Market (TAM)

6. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Segmentation

6.1. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

RNA Interference (RNAi)

RNA Antisense

6.2. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Enabling Technology

Enabled Technology

6.3. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Genetic Disorder

Ophthalmology

Hematological Disorders

Acute Hepatic Porphyria (AHP)

Other Therapeutic Areas

6.4. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research Institutes

Hospitals And Clinics

6.5. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Sub-Segmentation Of RNA Interference (RNAi), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Interfering RNA (siRNA)

MicroRNA (miRNA)

6.6. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Sub-Segmentation Of RNA Antisense, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antisense Oligonucleotides (ASOs)

Antisense RNA

7. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Regional And Country Analysis

7.1. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

8.1. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

9.1. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

9.2. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

10.1. India Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

11.1. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

11.2. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

12.1. Australia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

13.1. Indonesia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

14.1. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

14.2. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

15.1. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

15.2. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

16.1. UK Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

17.1. Germany Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

18.1. France Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

19.1. Italy Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

20.1. Spain Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

21.1. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

21.2. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

22.1. Russia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

23.1. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

23.2. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

24.1. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

24.2. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

25.1. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

25.2. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

26.1. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

26.2. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

27.1. Brazil Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

28.1. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

28.2. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

29.1. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Overview

29.2. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Competitive Landscape And Company Profiles

30.1. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Competitive Landscape

30.2. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Regeneron Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Other Major And Innovative Companies

31.1. Houston Methodist Hospital

31.2. BioNTech

31.3. University of Oxford

31.4. Alnylam Pharmaceuticals

31.5. Sarepta Therapeutics

31.6. Flagship Pioneering

31.7. Ionis Pharmaceuticals

31.8. Akcea Therapeutics Inc

31.9. Arrowhead Pharmaceuticals

31.10. Dicerna Pharmaceuticals

31.11. Wave Life Sciences

31.12. Pharmaceutical Technology

31.13. Quark Pharmaceuticals

31.14. Tekmira Pharmaceuticals

31.15. ReCode Therapeutics

32. Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

34. Recent Developments In The Ribose-Nucleic Acid (RNA)-Based Therapeutics Market

35. Ribose-Nucleic Acid (RNA)-Based Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Ribose-Nucleic Acid (RNA)-Based Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Sub-Segmentation Of RNA Interference (RNAi), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Sub-Segmentation Of RNA Antisense, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: F. Hoffmann-La Roche AG Financial Performance
  • Table 78: Eli Lilly and Company Financial Performance
  • Table 79: Novo Nordisk A/S Financial Performance
  • Table 80: Regeneron Pharmaceuticals Financial Performance
  • Table 81: Biogen Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Sub-Segmentation Of RNA Interference (RNAi), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Sub-Segmentation Of RNA Antisense, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Ribose-Nucleic Acid (RNA)-Based Therapeutics Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: F. Hoffmann-La Roche AG Financial Performance
  • Figure 78: Eli Lilly and Company Financial Performance
  • Figure 79: Novo Nordisk A/S Financial Performance
  • Figure 80: Regeneron Pharmaceuticals Financial Performance
  • Figure 81: Biogen Inc. Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

Read More About Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Ribose-Nucleic Acid (RNA)-Based Therapeutics Global Market Report 2025 – By Type (RNA Interference (RNAi), RNA Antisense), By Technology (Enabling Technology, Enabled Technology), By Therapeutic Area (Oncology, Genetic D...

View Report

mRNA Therapeutics Global Market Report 2025 – By Product (Vaccines, Drugs), By Application (Infectious Diseases, Oncology, Rare Genetic Diseases, Respiratory Diseases, Other Applications), By End Use (Hospitals And Clini...

View Report

Nucleic Acid Based Gene Therapy Global Market Report 2025 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By App...

View Report

RNA Targeting Small Molecules Therapeutics Global Market Report 2025 – By Offering (mRNA (Messenger Ribonucleic Acid) Translation Modulators, RNA (Ribonucleic Acid) Splicing Modification, Direct RNA (Ribonucleic Acid) Ta...

View Report

RNA Targeting Small Molecule Drug Discovery Global Market Report 2025 – By Target RNA Type (Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)), By Technology (CRISPR-Cas9, RNA A...

View Report

Antisense & RNAi Therapeutics Global Market Report 2025 – By Technology (RNA Interference, Antisense RNA), By Route of Administration (Intravenous Injections, Intra-dermal Injections, Other Delivery Methods), By Indicati...

View Report

Oligonucleotide Therapy Global Market Report 2025 – By Type (Antisense Oligonucleotide, Aptamer, Other Types), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney D...

View Report

Poly ADP-Ribose Polymerase (PARP) Inhibitor Global Market Report 2025 – By Drug Type (Talazoparib, Veliparib, Olaparib, Other Drug Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Oth...

View Report

Frequently Asked Questions

The ribose-nucleic acid (RNA)-based therapeutics refer to a class of medical treatments that utilize ribose-nucleic acid (RNA) molecules to influence cellular processes, typically by targeting specific genetic sequences. These therapies are designed to treat various conditions, including genetic disorders, cancers, and infectious diseases, by modulating gene expression, protein production, or cellular signaling pathways. For further insights on this market, request a sample here

The market major growth driver - Increasing Prevalence Of Cancer On The RNA-Based Therapeutics Market. For further insights on this market, request a sample here

The ribose-nucleic acid (rna)-based therapeutics market size has grown strongly in recent years. It will grow from $15.79 billion in 2024 to $17.22 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to investment and funding growth, the discovery of RNA interference (RNAi), clinical successes of antisense oligonucleotides (ASOs), regulatory support and frameworks, and collaborations, and partnerships. The ribose-nucleic acid (rna)-based therapeutics market size is expected to see strong growth in the next few years. It will grow to " $24.11 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to the expansion of indications, rising market demand and adoption, regulatory support, integration of AI and machine learning, and emerging applications in rare diseases. Major trends in the forecast period include advanced delivery systems, multi-target RNA therapeutics, customized RNA therapies, regulatory advancements, and commercialization and market growth. For further insights on this market, request a sample here

The ribose-nucleic acid (rna)-based therapeuticsmarket covered in this report is segmented –
1) By Type: RNA Interference (RNAi); RNA Antisense
2) By Technology: Enabling Technology; Enabled Technology
3) By Therapeutic Area: Oncology; Genetic Disorder; Ophthalmology; Hematological Disorders; Acute Hepatic Porphyria (AHP); Other Therapeutic Areas
4) By End User: Research Institutes; Hospitals And Clinics Subsegments:
1) By RNA Interference (RNAi): Small Interfering RNA (siRNA); MicroRNA (miRNA)
2) By RNA Antisense: Antisense Oligonucleotides (ASOs); Antisense RNA For further insights on this market, request a sample here

North America was the largest region in the ribose-nucleic acid (RNA)-based therapeutics market in 2024. The regions covered in the ribose-nucleic acid (RNA)-based therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the ribose-nucleic acid (RNA)-based therapeutics market are F. Hoffmann-La Roche AG, Eli Lilly and Company, Novo Nordisk A/S, Regeneron Pharmaceuticals, Biogen Inc., Houston Methodist Hospital, BioNTech, University of Oxford, Alnylam Pharmaceuticals, Sarepta Therapeutics, Flagship Pioneering, Ionis Pharmaceuticals, Akcea Therapeutics Inc, Arrowhead Pharmaceuticals, Dicerna Pharmaceuticals, Wave Life Sciences, Pharmaceutical Technology, Quark Pharmaceuticals, Tekmira Pharmaceuticals, ReCode Therapeutics, Arbutus Biopharma Corporation, Benitec Biopharma Inc., Olix Pharmaceuticals, Alltrna Inc., Orbital Therapeutics . For further insights on this market, request a sample here.

Major trends in this market include Advancements In RNA-Based Therapeutics With mRNA-Based Vaccines. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Ribose-Nucleic Acid (RNA)-Based Therapeutics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon